Trials / Completed
CompletedNCT02299557
The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients
A Double Blind Study to Examine the Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- RDD Pharma Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This is an double blinded, cross-over study to determine the effect of Oxymetazoline gel on anal resting pressure and fecal incontinence in patients with spinal cord injury. Approximately 17 subjects are expected to complete this 10 weeks study that will include two treatment periods of 4 weeks each, and one 2 weeks wash out period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxymetazoline gel | Oxymetazoline gel applied intra-anally once daily |
| DRUG | Placebo gel | Placebo gel applied intra-anally once daily |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-06-01
- Completion
- 2015-07-01
- First posted
- 2014-11-24
- Last updated
- 2015-07-28
Locations
1 site across 1 country: Hungary
Source: ClinicalTrials.gov record NCT02299557. Inclusion in this directory is not an endorsement.